Cargando…
YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells
OBJECTIVE: To identify the role of YAP in cisplatin resistance in human ovarian cancer cells and in the regulation of autophagy in these cancer cells. MATERIALS AND METHODS: The cisplatin-sensitive OV2008 parental cell line and its cisplatin-resistant variant C13K were cultured. RNA interference was...
Autores principales: | Xiao, Lan, Shi, Xiao-Yan, Zhang, Ying, Zhu, Ying, Zhu, Lin, Tian, Wang, Zhu, Bing-Kun, Wei, Zhao-Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806764/ https://www.ncbi.nlm.nih.gov/pubmed/27073322 http://dx.doi.org/10.2147/OTT.S102837 |
Ejemplares similares
-
Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway
por: Xiao, Lan, et al.
Publicado: (2021) -
Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer
por: He, Jing, et al.
Publicado: (2019) -
YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
por: Yang, Chao, et al.
Publicado: (2017) -
Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
por: Yang, Chao, et al.
Publicado: (2022) -
MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy
por: Cai, Yi, et al.
Publicado: (2021)